 Methicillin-Resistant Staphylococcus aureus
"Methicillin-Resistant Staphylococcus aureus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A strain of Staphylococcus aureus that is non-susceptible to the action of METHICILLIN. The mechanism of resistance usually involves modification of normal or the presence of acquired PENICILLIN BINDING PROTEINS.
| Descriptor ID |
D055624
|
| MeSH Number(s) |
B03.300.390.400.800.750.100.500 B03.353.500.750.750.100.500 B03.510.100.750.750.100.500 B03.510.400.790.750.100.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Methicillin-Resistant Staphylococcus aureus".
Below are MeSH descriptors whose meaning is more specific than "Methicillin-Resistant Staphylococcus aureus".
This graph shows the total number of publications written about "Methicillin-Resistant Staphylococcus aureus" by people in this website by year, and whether "Methicillin-Resistant Staphylococcus aureus" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 2 | 1 | 3 | | 2009 | 3 | 0 | 3 | | 2010 | 4 | 3 | 7 | | 2011 | 8 | 1 | 9 | | 2012 | 14 | 3 | 17 | | 2013 | 8 | 1 | 9 | | 2014 | 3 | 5 | 8 | | 2015 | 7 | 3 | 10 | | 2016 | 5 | 2 | 7 | | 2017 | 5 | 5 | 10 | | 2018 | 4 | 3 | 7 | | 2019 | 7 | 2 | 9 | | 2020 | 5 | 2 | 7 | | 2021 | 7 | 2 | 9 | | 2022 | 11 | 0 | 11 | | 2023 | 9 | 1 | 10 | | 2024 | 5 | 1 | 6 | | 2025 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Methicillin-Resistant Staphylococcus aureus" by people in Profiles.
-
Enroth TJ, Severn MM, Costa FG, Bovee AR, Wilkening RV, Nguyen DT, Langou?t-Astri? C, Horswill AR. Global changes in Staphylococcus aureus virulence and metabolism during colonization of healthy skin. Infect Immun. 2025 Apr 08; 93(4):e0002825.
-
Lyon LM, Marroquin SM, Thorstenson JC, Joyce LR, Fuentes EJ, Doran KS, Horswill AR. Genome-wide mutagenesis identifies factors involved in MRSA vaginal colonization. Cell Rep. 2025 Mar 25; 44(3):115421.
-
Ho EC, Olson KE, Butler M, Birkholz M, Miller K, MacBrayne CE, Jung S, Messacar K, Asturias EJ, Dominguez SR. Clinical Impact of Pleural Fluid Streptococcus pneumoniae Polymerase Chain Reaction Testing in Children With Complicated Pneumonia. Clin Infect Dis. 2024 12 17; 79(6):1487-1494.
-
Bessesen MT. Interventions targeting the nasal microbiome to eradicate methicillin-resistant Staphylococcusaureus. Clin Microbiol Infect. 2025 Feb; 31(2):190-193.
-
Kaplan JB, Horswill AR. Micrococcal nuclease regulates biofilm formation and dispersal in methicillin-resistant Staphylococcus aureus USA300. mSphere. 2024 May 29; 9(5):e0012624.
-
Costa FG, Mills KB, Crosby HA, Horswill AR. The Staphylococcus aureus regulatory program in a human skin-like environment. mBio. 2024 May 08; 15(5):e0045324.
-
De M, Serpa G, Zuiker E, Hisert KB, Liles WC, Manicone AM, Hemann EA, Long ME. MEK1/2 inhibition decreases pro-inflammatory responses in macrophages from people with cystic fibrosis and mitigates severity of illness in experimental murine methicillin-resistant Staphylococcus aureus infection. Front Cell Infect Microbiol. 2024; 14:1275940.
-
Bhattacharya M, Horswill AR. The role of human extracellular matrix proteins in defining Staphylococcus aureus biofilm infections. FEMS Microbiol Rev. 2024 Jan 12; 48(1).
-
Zehr EP, Erzen CL, Oshima K, Langouet-Astrie CJ, LaRiviere WB, Shi D, Zhang F, McCollister BD, Windham SL, Rizzo AN, Bastarache JA, Horswill AR, Schmidt EP, Kwiecinski JM, Colbert JF. Bacterial pneumonia-induced shedding of epithelial heparan sulfate inhibits the bactericidal activity of cathelicidin in a murine model. Am J Physiol Lung Cell Mol Physiol. 2024 02 01; 326(2):L206-L212.
-
Yellepeddi VK, Lindley B, Radetich E, Kumar S, Bhakta Z, Leclair L, Parrot M, Young DC. Population pharmacokinetics and target attainment analysis of vancomycin after intermittent dosing in adults with cystic fibrosis. Antimicrob Agents Chemother. 2024 01 10; 68(1):e0099223.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|